Filing search / Ownership / Acorda Therapeutics, Inc. / Page 35

8-K/A

w80x3bo9

6 Oct 06

Entry into a Material Definitive Agreement

12:00am

8-K

pp3 d58xvyptv

5 Oct 06

Entry into a Material Definitive Agreement

12:00am

8-K

3dpa1gddh

25 Sep 06

Acorda Therapeutics Announces Positive Results of Phase 3 Study of Fampridine- SR on Walking in People with Multiple Sclerosis

12:00am

8-K

xakq2n47zww bd

21 Sep 06

Other Events

12:00am

UPLOAD

uoej 0593vcprodlp3m

19 Aug 06

Letter from SEC

12:00am

8-K

kasnx02oyqa8

17 Aug 06

Entry into a Material Definitive Agreement

12:00am

8-K

6gzofb

7 Aug 06

Acorda Therapeutics Announces Directors Stepping Down

12:00am

8-K

a3h t84400

4 Aug 06

Acorda Therapeutics Reports Second Quarter 2006 Financial Results

12:00am

8-K

hest 6qoqhorn3p5

12 Jul 06

Regulation FD Disclosure

12:00am

10-Q

2e92ul

12 May 06

Quarterly report

12:00am

8-K

0nj0f1

5 May 06

Acorda Therapeutics Reports First Quarter 2006 Financial Results

12:00am

8-K

w4oickxkbcg

17 Apr 06

Regulation FD Disclosure

12:00am

10-K

3cs18mjn

31 Mar 06

Annual report

12:00am

8-K

us6jhupvf qyak1pu

31 Mar 06

Acorda Therapeutics Reports Fourth Quarter and Full Year 2005 Financial Results

12:00am

8-K

6kph4vhg98be os6

23 Mar 06

Entry into a Material Definitive Agreement

12:00am

8-K

qxyl31vv4madcg

15 Mar 06

Other Events

12:00am

8-K

5u9vlf

6 Mar 06

Other Events

12:00am

S-8

95ercu4cgz mkghg85f

14 Feb 06

Registration of securities for employees

12:00am

424B4

7itywk ijt

10 Feb 06

Prospectus supplement with pricing info

12:00am